Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity

Altered Levels of Fecal Chromogranins and Secretogranins in IBS: Relevance for Pathophysiology and Symptoms?

(2012) Lena Öhman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis

(2012) Magdy El-Salhy et al.   DIGESTIVE DISEASES AND SCIENCES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Enteroendocrine cells in terminal ileal Crohn's disease

(2012) Gordon W. Moran et al.   Journal of Crohns & Colitis

The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors

(2011) Ben Lawrence et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

(2010) Lena Öhman et al.   Nature Reviews Gastroenterology & Hepatology

Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders

(2010) A. Bartolomucci et al.   NEUROSCIENCE

Regulatory peptides from chromogranin A and secretogranin II: Putative modulators of cells and tissues involved in inflammatory conditions

(2009) Karen B. Helle   REGULATORY PEPTIDES

The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity

(2009) Peiman Shooshtarizadeh et al.   REGULATORY PEPTIDES

Plasma chromogranin a in patients with inflammatory bowel disease

(2008) Valentina Sciola et al.   INFLAMMATORY BOWEL DISEASES

Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

(2008) Mats Stridsberg et al.   REGULATORY PEPTIDES